Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain.

Antonio Solana-AltabellaBlanca BoludaRebeca Rodríguez-VeigaIsabel CanoEvelyn Acuña-CruzAlbert BlancoJavier Marco-AyalaRosalía de la PuertaÁlvaro Díaz-GonzálezJosé L PiñanaJaime SanzAmparo SempereJosé CerveraEva BarragánClaudia SargasOctavio Ballesta-LópezJuan Eduardo Megías-VericatDavid Martínez-CuadrónMiguel Á SanzPau Montesinos
Published in: European journal of haematology (2021)
Data from this study suggest that there is a substantial healthcare resource utilization and cost burden on R/R FLT3mut AML patients in Spain receiving active treatments.